![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Institut für experimentelle und klinische Pharmakologie und Toxikologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Germany (C.B., A.D.); Medizinische Klinik II, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Germany (T.K., I.S., F.S.); Institut für Pharmakologie, Klinikum der Universität zu Köln, Köln, Germany (E.S.); and Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany (G.R.)
Global myocardial low flow ischemia results in an uniform suppression of norepinephrine (NE) overflow from the heart. We hypothesized that opening of neuronal ATP-sensitive potassium (KATP) channels as well as activation of the extraneuronal monoamine transporter (EMT) mediates attenuation of NE overflow during low flow ischemia. Isolated rat hearts were subjected to low coronary flow of 0.4 ml min-1. Release of endogenous NE was induced by electrical field stimulation. EMT activity was measured as the transport rate of the substrate N-[methyl-3H]4-phenylpyridinium ([3H]MPP+). NE overflow decreased by 57 ± 2% within 120 min of low flow. Five minutes of reperfusion at normal flow (8 ml min-1) restored NE overflow to baseline. KATP channel blockade with glibenclamide as well as EMT blockade with corticosterone increased NE overflow 1.5- and 2-fold at 120 min of low flow, whereas neither drug affected NE overflow in the absence of flow reduction. At normal flow, KATP channel opening with cromakalim suppressed NE overflow, both in the presence and absence of EMT blockade (14 ± 4 and 9 ± 1%). However, cromakalim had no effect on EMT activity as indicated by an unaffected [3H]MPP+ overflow. In conclusion, activation of both KATP channels and EMT mediate suppression of NE overflow during low flow ischemia. KATP channels impair NE release directly at presynaptic nerve endings, whereas EMT increases NE elimination in a manner independent of KATP channels.
Address correspondence to: Christof Burgdorf, Institut für experimentelle und klinische Pharmakologie und Toxikologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. E-mail: chbrg{at}compuserve.de
This article has been cited by other articles:
![]() |
T.-M. Lee, M.-S. Lin, and N.-C. Chang Effect of pravastatin on sympathetic reinnervation in postinfarcted rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3617 - H3626. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, K. Patel, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox Acute antihypertensive action of Tempol in the spontaneously hypertensive rat Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3246 - H3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Tan, A. Al Abed, and J. A. Brock Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional {alpha}2-adrenoceptors J. Physiol., June 1, 2007; 581(2): 757 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hibino and Y. Kurachi A New Insight Into the Pathogenesis of Coronary Vasospasm Circ. Res., March 17, 2006; 98(5): 579 - 581. [Full Text] [PDF] |
||||
![]() |
R. Kakkar, B. Ye, D. A. Stoller, M. Smelley, N.-Q. Shi, K. Galles, M. Hadhazy, J. C. Makielski, and E. M. McNally Spontaneous Coronary Vasospasm in KATP Mutant Mice Arises From a Smooth Muscle-Extrinsic Process Circ. Res., March 17, 2006; 98(5): 682 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujii, T. Yamazaki, T. Akiyama, S. Sano, and H. Mori Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region Cardiovasc Res, October 1, 2004; 64(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||